<DOC>
	<DOCNO>NCT00349440</DOCNO>
	<brief_summary>The purpose study evaluate effect topical cyclosporine ophthalmic solution 0.05 % ( Restasis , Allergan ) sign symptom dry eye patient undergoing LASIK photorefractive keratectomy ( PRK ) .</brief_summary>
	<brief_title>Efficacy Cyclosporine Prevention Treatment Dry Eye Symptoms Following LASIK Photorefractive Keratectomy</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Males female &gt; 18 year old Mildmoderate symptom dry eye prior surgery Scheduled undergo bilateral LASIK PRK Likely complete study visit able provide inform consent Prior use topical cyclosporine within last 1 year Known contraindication study medication ingredient Female child bear potential use reliable method birth control , pregnant lactating female . Ocular disorder Active ocular disease uncontrolled systemic disease Active ocular allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Dry eye</keyword>
</DOC>